References
- Ring J, Hein R, Gauger A, Desloratadine in the treatment of chronic idiopathic urticaria. Allergy (2001) 96: 28–32.
- Lippert U, Mo¨ller A, Welker P et al, Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists. Exp Dermatol (2000) 9: 118–24.
- Henz BM, The pharmacologic profile of desloratadine: a review. Allergy (2001) 56: 7–13.
- Neittaanma¨ki H, Fra¨ ki JE, Gibson JR, Comparison of the new antihistamine acrivastine (BW825C) versus cypro- heptadine in the treatment of idiopathic cold urticaria. Dermatologia (1988) 177: 98–103.
- Juhlin L, de Vos C, Rihoux J-P, Inhibition effect of cetirizine on histamine-induced and 48/80-induced wheals and flares, experimental dermographism, and cold-induced urticaria. J Allergy Clin Immunol (1987) 80: 599–602.
- Geha RS, Meltzer EO, Desloratadine: a new, nonsedating, oral antihistamine. J Allergy Clin Immunol (2001) 107: 751–62.
- Kreuter W, Hey JA, Authes J et al, Preclinical pharmacology of desloratadine, a selective and non- sedating histamine H1 receptor antagonist: 1st commu- nication: receptor selectivity, antihistaminic activity and antiallergenic effects. Arzneimittelforschung (2000) 50: 345–52.
- Kleine-Tebbe J, Josties C, Frank G et al, Inhibition of IgE mediated and IgE-independent histamine release from human basophil leukocytes in vitro by H1-antagonist, descarbo-ethoxy-loratadine. J Allergy Clin Immunol (1994) 93: 494–500.
- Genovese A, Patella V, De Crescenzo G et al, Loratadine and deethoxycarbonylloratidine inhibit the immuno- logical release of mediators from human Fc epsilon RIzcells. Clin Exp Allergy (1997) 27: 559–67.
- He S, Walls AF, Human mast cell tryptase: a stimulus for microvascular leakage and mast cell activation. Eur J Pharmacol (1997) 328: 89–97.
- Maltby NH, Ind PW, Causon RC et al, Leukotriene E4 release in cold urticaria. Clin Exp Allergy (1989) 19: 33–6.
- Friedman PS, Perzano´ wska M, McGuire C et al, New therapeutic indications for Cys-LT, antagonists: atopic dermatitis and urticaria. Clin Exp Allergy Reviews (2001) 1: 156–9.
- Nettis E, Dambra P, D’Oronzio L et al, Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Arch Dermatol (2001) 137: 99–100.
- Pacor ML, Di Lorenzo G, Corrocher R, Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treat- ment with montelukast and cetirizine in patients with chronic urticaria with intoloerance to food additive and/ or acetylsalicylic acid. Clin Exp Allergy (2001) 31: 1607–14.
- Juhlin L, Cold urticaria with persistent weals. Br J Dermatol (1981) 104: 705–7.
- Juhlin L, Shelley WB, Role of mast cell and basophil in cold urticaria with associated systemic reactions. J Am Med Assn (1961) 177: 311–17.
- Sarkany I, Turk JL, Delayed type hypersensitivity to cold. Proc Royal Soc Med (1965) 58: 622–3.
- Ba¨ck O, Larsen A, Delayed cold urticaria. Acta Derm Venereol (1978) 58: 369–71.
- Soter NA, Joshi NP, Twarog FJ et al, Delayed cold induced urticaria. A dominantly inherited disorder. J Allergy Clin Immunol (1977) 59: 294–7.